Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-03-05 Sale | 2025-03-07 8:01 pm | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 10,000 | $30.15 | $301,511 | 1,292,987 (Direct) | View |
| 2025-02-05 Sale | 2025-02-07 8:01 pm | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 15,000 | $40.58 | $608,700 | 1,302,987 (Direct) | View |
| 2025-01-08 Sale | 2025-01-10 8:00 pm | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 15,000 | $48.85 | $732,693 | 1,309,487 (Direct) | View |
| 2024-12-04 Sale | 2024-12-06 8:01 pm | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 15,000 | $46.58 | $698,654 | 1,324,487 (Direct) | View |
| 2024-11-06 Sale | 2024-11-08 8:01 pm | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 15,000 | $59.22 | $888,320 | 1,339,487 (Direct) | View |
| 2024-10-02 Sale | 2024-10-04 8:01 pm | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 40,000 | $56.23 | $2,249,307 | 1,354,487 (Direct) | View |
| 2024-09-04 Sale | 2024-09-06 8:02 pm | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 40,000 | $47.62 | $1,904,841 | 1,394,487 (Direct) | View |
| 2024-08-07 Sale | 2024-08-09 8:05 pm | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 40,000 | $40.62 | $1,624,764 | 1,434,487 (Direct) | View |
| 2024-07-05 Sale | 2024-07-05 8:01 pm | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 15,000 | $37.26 | $558,900 | 1,474,487 (Direct) | View |
| 2020-12-01 Sale | 2020-12-02 4:17 pm | BridgeBio Pharma Inc. | BBIO | HENDERSON MICHAEL THOMAS Chief Business Officer | 10,000 | $51.52 | $515,204 | 282,493 (Direct) | View |
| 2020-11-16 Sale | 2020-11-18 7:43 pm | BridgeBio Pharma Inc. | BBIO | HENDERSON MICHAEL THOMAS Chief Business Officer | 10,000 | $45 | $450,000 | 471,868 (Direct) | View |
| 2020-11-02 Sale | 2020-11-03 4:05 pm | BridgeBio Pharma Inc. | BBIO | HENDERSON MICHAEL THOMAS Chief Business Officer | 10,000 | $38.36 | $383,558 | 296,033 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-05-29 Option Award | 2025-06-02 4:35 pm | N/A 2035-05-29 | Spyre Therapeutics Inc. | SYRE | HENDERSON MICHAEL THOMAS Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2025-01-31 Exercise | 2025-01-31 8:00 pm | N/A N/A | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 8,500 | $22.86 | 1,707,999 (Direct) | View |
| 2025-01-31 Exercise | 2025-01-31 8:00 pm | N/A 2033-12-18 | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 8,500 | $0 | 1,707,999 (Direct) | View |
| 2025-01-10 Other | 2025-01-14 5:16 pm | N/A N/A | Spyre Therapeutics Inc. | SYRE | HENDERSON MICHAEL THOMAS Director | 105,379 | $0 | 210,758 (Direct) | View |
| 2024-12-09 Option Award | 2024-12-11 8:02 pm | N/A 2034-12-09 | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 357,036 | $0 | 357,036 (Direct) | View |
| 2024-05-14 Option Award | 2024-05-16 4:10 pm | N/A 2034-05-14 | Spyre Therapeutics Inc. | SYRE | HENDERSON MICHAEL THOMAS Director | 11,323 | $0 | 11,323 (Direct) | View |
| 2023-12-18 Option Award | 2023-12-20 8:00 pm | N/A 2033-12-18 | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 398,512 | $0 | 398,512 (Direct) | View |
Ownership(A) | 2023-07-17 5:04 pm | N/A N/A | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 0 | $0 | 1,489,487 (Direct) | View |
Ownership | 2023-07-13 6:42 pm | N/A N/A | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 0 | $0 | 1,404,304 (Direct) | View |
Ownership | 2023-06-30 5:13 pm | N/A 2033-06-22 | Aeglea BioTherapeutics Inc. | AGLE | HENDERSON MICHAEL THOMAS Director | 0 | $0 | 1,950,000 (Direct) | View |
Ownership | 2021-02-25 8:58 pm | N/A N/A | ARYA Sciences Acquisition Corp IV | ARYD | HENDERSON MICHAEL THOMAS Director | 0 | $0 | 30,000 (Direct) | View |
| 2020-12-15 Option Award | 2020-12-17 4:05 pm | N/A 2030-04-01 | BridgeBio Pharma Inc. | BBIO | HENDERSON MICHAEL THOMAS Chief Business Officer | 9,792 | $0 | 9,792 (Direct) | View |
| 2020-12-01 Exercise | 2020-12-02 4:17 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | HENDERSON MICHAEL THOMAS Chief Business Officer | 10,000 | $1.05 | 282,493 (Direct) | View |
| 2020-12-01 Exercise | 2020-12-02 4:17 pm | 2020-05-19 2029-09-24 | BridgeBio Pharma Inc. | BBIO | HENDERSON MICHAEL THOMAS Chief Business Officer | 10,000 | $0 | 282,493 (Direct) | View |
| 2020-11-16 Exercise | 2020-11-18 7:43 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | HENDERSON MICHAEL THOMAS Chief Business Officer | 10,000 | $1.05 | 471,868 (Direct) | View |
| 2020-11-16 Exercise | 2020-11-18 7:43 pm | 2020-05-19 2029-09-24 | BridgeBio Pharma Inc. | BBIO | HENDERSON MICHAEL THOMAS Chief Business Officer | 22,813 | $0 | 471,868 (Direct) | View |
| 2020-11-16 Tax Withholding | 2020-11-18 7:43 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | HENDERSON MICHAEL THOMAS Chief Business Officer | 6,353 | $44.33 | 471,868 (Direct) | View |
| 2020-11-02 Exercise | 2020-11-03 4:05 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | HENDERSON MICHAEL THOMAS Chief Business Officer | 10,000 | $1.05 | 296,033 (Direct) | View |
| 2020-11-02 Exercise | 2020-11-03 4:05 pm | 2020-05-19 2029-09-24 | BridgeBio Pharma Inc. | BBIO | HENDERSON MICHAEL THOMAS Chief Business Officer | 10,000 | $0 | 296,033 (Direct) | View |